GSA Capital Partners’s Surgery Partners SGRY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-37,891
Closed -$901K 1974
2024
Q2
$901K Buy
37,891
+27,077
+250% +$695K 0.06% 574
2024
Q1
$323K Buy
+10,814
New +$338K 0.03% 1174
2023
Q1
Sell
-27,905
Closed -$777K 1891
2022
Q4
$777K Sell
27,905
-24,319
-47% -$644K 0.1% 342
2022
Q3
$1.22M Buy
+52,224
New +$1.67M 0.16% 91
2022
Q1
Sell
-12,239
Closed -$654K 1791
2021
Q4
$654K Buy
+12,239
New +$568K 0.08% 422
2021
Q1
Sell
-27,345
Closed -$793K 1451
2020
Q4
$793K Buy
+27,345
New +$681K 0.13% 202
2020
Q1
Sell
-35,761
Closed -$560K 1505
2019
Q4
$560K Buy
+35,761
New +$406K 0.07% 580
2018
Q4
Sell
-66,638
Closed -$1.1M 1701
2018
Q3
$1.1M Buy
+66,638
New +$1.06M 0.06% 624
2018
Q2
Sell
-12,929
Closed -$222K 1905
2018
Q1
$222K Buy
+12,929
New +$201K 0.01% 1435

Other funds holding SGRY

GSA Capital Partners's SGRY Position: Q3 2024 in Review

GSA Capital Partners sold out of Surgery Partners (SGRY) in Q3 2024, closing a stake of 37,891 shares — an estimated $901K sold.

GSA Capital Partners first reported a position in SGRY in Q1 2018 and held it in 9 quarters. The position peaked at $1.22M in Q3 2022. 183 funds tracked by Wall St. Rank hold SGRY as of Q3 2024.

  • GSA Capital Partners reported no remaining Surgery Partners position as of Q3 2024 after selling out during the quarter.
  • GSA Capital Partners sold 37,891 Surgery Partners shares in Q3 2024, an estimated $901K.
  • GSA Capital Partners first reported a position in Surgery Partners in Q1 2018 and held it in 9 quarters.
  • GSA Capital Partners's Surgery Partners position peaked at $1.22M in Q3 2022.
  • 183 funds tracked by Wall St. Rank held Surgery Partners as of Q3 2024.

Based on GSA Capital Partners's 13F filing for Q3 2024, filed 5 Nov 2024.